Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin in T-cell Depleted HSCT for MDS and AML
NCT00629798Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2008
- Primary completion
- Oct 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of palifermin in oral mucositis (OM), sponsored by Memorial Sloan Kettering Cancer Center. Started Feb 2008; status: completed.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00629798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629798.